Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Antonio Martínez-Yélamos"'
Autor:
Pablo Arroyo-Pereiro, Lydia García-Serrano, Francisco Morandeira, Blanca Urban, Virginia Mas, Mario Framil, Isabel León, Albert Muñoz-Vendrell, Elisabet Matas, Lucía Romero-Pinel, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos, Laura Bau
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe role of the kappa-free light chain (kFLC) in the diagnosis of multiple sclerosis (MS) and, to a lesser extent, its role as a medium-term prognostic marker have been extensively studied. This study aimed to explore its potential as a l
Externí odkaz:
https://doaj.org/article/dd12a4f6cd644865af0293c895a6fbe3
Autor:
Lucía Romero-Pinel, Laura Bau, Elisabet Matas, Isabel León, Roser Juvany, Ramon Jódar, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267504 (2022)
BackgroundThe efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining real-world outcomes is essential to evaluate the cost-effectiveness of different therap
Externí odkaz:
https://doaj.org/article/06d65d7b261d43cdb7a8d188b95f7144
Autor:
Albert Muñoz-Vendrell, Pablo Arroyo-Pereiro, Isabel León, Laura Bau, Elisabet Matas, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos, Lucía Romero-Pinel
Publikováno v:
Journal of Neurology. 270:2559-2566
Background Natalizumab (NTZ) and ocrelizumab (OCR) can be used for the treatment of relapsing–remitting multiple sclerosis (RRMS). In patients treated with NTZ, screening for JC virus (JCV) is mandatory, and a positive serology usually requires a c
Autor:
Pablo Arroyo-Pereiro, Albert Muñoz-Vendrell, Laura Bau, Elisabet Matas, Lucia Romero-Pinel, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos
Publikováno v:
European Neurology. 86:73-77
Introduction: Prior studies have suggested that cardiovascular risk factors (CVRFs) can affect the prognosis of multiple sclerosis (MS). The aim of this study was to assess if CVRFs affect the early course of MS. Methods: A retrospective observationa
Autor:
S. Yagüe, Jordi Pedro, Belia García, Hatice Kumru, Josep Valls-Solé, Pere Cardona, Antonio Martínez-Yélamos, Jordi Montero, Misericordia Veciana, Blanca Lara, Helena Quesada
Publikováno v:
Journal of Clinical Neurophysiology. 40:63-70
Transcranial direct current stimulation (tDCS) can change the excitability of the central nervous system and contribute to motor recovery of stroke patients. The aim of our study was to examine the short- and long-term effects of real versus sham bih
Autor:
Lucía Romero-Pinel, Laura Bau, Elisabet Matas, Isabel León, Albert Muñoz-Vendrell, Pablo Arroyo, Cristina Masuet-Aumatell, Antonio Martínez-Yélamos, Sergio Martínez-Yélamos
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) most commonly experience their first symptoms between 20 and 40 years of age. The objective of this study was to investigate how the age at which the first symptoms of RRMS occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1d228ee10d2ce3fccefb6d0022f1de
http://hdl.handle.net/2445/190239
http://hdl.handle.net/2445/190239
Autor:
Sara Yagüe, Misericordia Veciana, Antonio Martínez-Yélamos, Jordi Pedro, Pere Cardona, Helena Quesada, Blanca Lara, Hatice Kumru, Belia García, Jordi Montero, Josep Valls-Solé
Publikováno v:
Clinical Neurophysiology. 141:S130
Autor:
Beliu García Parra, Josep M. Guiu, Pilar Modamio, Antonio Martínez Yélamos, Eduardo Mariño Hernández, Mónica Povedano
Publikováno v:
Revista de Neurología. 75:261
Autor:
Sònia Abilleira, Dolores Cocho, MOISES GARCES REDONDO, Angel Ois, POL CAMPS-RENOM, Paloma Mora, Sandra Boned Riera, Manuel Gomez-Choco, Antonio Martínez Yélamos, Cristian Tebé, Sebastian Remollo Friedemann, Marc Ribo, Alejandro Tomasello, Natalia Pérez de la Ossa, Xavier Ustrell
Publikováno v:
European Stroke Journal. 2:163-170
Introduction Endovascular thrombectomy was recently established as a new standard of care in acute ischemic stroke patients with large artery occlusions. Using small area health statistics, we sought to assess dissemination of endovascular thrombecto
Autor:
Sergi Amaro, Xabier Urra, Alejandro Tomasello, Joaquín Serena, Joan Martí-Fàbregas, A. Chamorro, MA de Miquel, Joan Perendreu, Joan Josep Baiges, Yolanda Silva, Anna Pellisé, Antoni Dávalos, Xavier Ustrell, Jordi Jiménez-Conde, Pilar Otermin, Jordi Sanahuja, Pilar Coscojuela, Sònia Abilleira, Carlos Castaño, Rafael Marés, R Delgado Mederos, Josep Maria Aragonés, Elisa Cuadrado-Godia, A Martínez Domeño, Marc Ribó, Francisco Purroy, Marta Rubiera, C van Eendenburg, N Cayuela, Juan Macho, Jurek Krupinski, L San Roman Manzanera, Ana Rodríguez-Campello, J Estela, Angel Ois, Meritxell Gomis, MC Nicolás, Mar Castellanos, Carlos A. Molina, JM Soler Insa, Eva Giralt, S Huertas, M Del Carmen Garcia, Moisés Garcés, Helena Quesada, Natalia Pérez de la Ossa, Manuel Gómez-Choco, J. Pagola, Sebastian Remollo, David Rodriguez-Luna, Paloma Mora, R Marín Bueno, Jordi Blasco, Sonia García, Victor Obach, L Cocho Calderón, Antonio M. López, Laura Dorado, David Cánovas, Jaume Roquer, Lucia Aja, Mónica Millán, Júlia Saura, R Martínez, Blanca Lara, E. López-Cancio, Miquel Gallofré, Leopoldo Guimaraens, Antonio Martínez-Yélamos, E. Palomeras, Pere Cardona, Marian Muchada
Publikováno v:
Stroke. 47:1381-1384
Background and Purpose— Since demonstration of the benefit of endovascular treatment (EVT) in acute ischemic stroke patients with proximal arterial occlusion, stroke care systems need to be reorganized to deliver EVT in a timely and equitable way.